Blog
GxP Technical Resources
Practical articles on systems validation, regulatory compliance and auditing in the pharmaceutical and medtech industry.
Featured
Data Governance in GxP Environments: Building a Foundation for AI-Ready Pharmaceutical Operations
In the pharmaceutical industry, data integrity has evolved from a compliance requirement to a strategic imperative. Regulatory frameworks such as FDA's 21 CFR Part 11 and EU Annex 11 establish foundational requirements f
User Requirements Specification: The Foundation of GxP System Lifecycle Management
In the regulated pharmaceutical and biotechnology industries, the User Requirements Specification (URS) serves as the cornerstone document that defines the intended use of computerized systems throughout their entire lif
Risk-Based Approach in GxP Systems Validation: Optimizing Regulatory Compliance Throughout the System Lifecycle
The pharmaceutical and biotechnology industries increasingly recognize risk-based approaches as fundamental to effective computerized systems validation. This methodology, supported by ICH Q9 Quality Risk Management guid
All articles
EMA Notice to Sponsors on the Validation and Qualification of Computerised Systems Used in Clinical Trials. April 2026
Last April, the EMA issued a notice to sponsors on the validation and qualification of computerised systems used in clinical trials.
Computer Systems Validation Master Plan: Strategic Framework for GxP Compliance
In regulated industries, computerized systems supporting GxP processes require systematic validation to ensure data integrity, patient safety, and regulatory compliance. The Computer Systems Validation Master Plan (CSV M
Audit Trail Requirements and Management in GxP System Validation and Operation
Audit trail functionality represents a cornerstone of data integrity in regulated environments. The FDA's 21 CFR Part 11 defines electronic records requirements, while EU Annex 11 establishes computerized system complian
Essential Elements of Physical and Logical Security Procedures in GxP Environments
Data integrity in GxP environments fundamentally depends on robust physical and logical security controls that protect computerized systems throughout their lifecycle. Regulatory frameworks including FDA's 21 CFR Part 11
Maintaining Validated State: A Critical Component of GxP System Lifecycle Management
In regulated GxP environments, achieving validation is only the beginning of a system's compliance journey. The validated state represents a controlled condition where systems consistently perform their intended function
Change Control in Computerized Systems: A Lifecycle Management Approach
Change control represents a cornerstone of computerized system validation within regulated environments. The dynamic nature of technology demands continuous adaptation while maintaining regulatory compliance and data int